Health Care · Pharmaceuticals
Enterprise value divided by EBITDA over the last 12 months. A common way to compare companies with different amounts of debt.
Latest EV/EBITDA
-1599.53x
As of Feb 4, 2025
Beyond EV/EBITDA, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/EBITDA |
|---|---|
| Feb 4, 2025 | -1599.53x |
| Jan 17, 2025 | -1492.82x |
| Jan 14, 2025 | -1877.39x |
| Jan 13, 2025 | -1450.14x |
| Dec 5, 2024 | -1458.67x |
| Nov 25, 2024 | -1454.41x |
| Oct 1, 2024 | -1454.41x |
| Sep 18, 2024 | -1458.67x |
EV/EBITDA = Enterprise Value / EBITDA (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/EBITDA is widely used because it removes the effects of financing and non-cash accounting items.
Read the general EV/EBITDA definition, formula, and analyst usage guide.
EV/EBITDA guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.